Literature DB >> 10494122

Tissue strength analysis of autologous and cadaveric allografts for the pubovaginal sling.

M L Lemer1, D C Chaikin, J G Blaivas.   

Abstract

The aim of this study was to compare the mechanical properties of autologous rectus fascia (ARF), two groups of commercially available cadaveric fascia lata commonly used in pubovaginal sling surgery [freeze-dried (FD) and solvent-dehydrated (SD)], and commercially available cadaveric dermal grafts (DG) evaluate differences in tissue strength and stiffness. We prospectively studied the maximum load to failure (MLF) and stiffness in 20 specimens of ARF, 20 specimens of FD, 20 specimens of SD, and 10 specimens of DG. Autologous fascia was obtained from patients undergoing pubovaginal sling operation utilizing rectus fascia. Cadaveric fascia was re-hydrated in saline. All specimens were then tailored into 1 x 1-cm samples and mounted onto the Instron tensiometer. Samples were loaded to failure at a 100% strain rate and force-elongation curves were generated. MLF was defined as the minimum force needed to tear the tissue. Stiffness was determined by the slope of the linear portion of the force/elongation curve between 5 and 15% strain. Statistical analysis was performed using Student's t-test. There is no statistical difference in both MLF and stiffness among ARF, SD, and DG. These data show that MLF and tissue stiffness of SD and DG are comparable to that of ARF. FD has a significantly lower MLF and is significantly less stiff than ARF, SD, and DG. The SD cadaveric fascia lata allograft and the cadaveric dermal allograft may be suitable alternatives to ARF for pubovaginal sling surgery. Neurourol. Urodynam. 18:497-503, 1999. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10494122     DOI: 10.1002/(sici)1520-6777(1999)18:5<497::aid-nau12>3.0.co;2-k

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  12 in total

Review 1.  Nonautologous sling materials.

Authors:  G M Ghoniem; D S Kapoor
Journal:  Curr Urol Rep       Date:  2001-10       Impact factor: 3.092

2.  Does size matter? Technical considerations of a regenerative tissue matrix for use in reconstructive surgery.

Authors:  Randall O Craft; Alanna M Rebecca; Colleen Flahive; William J Casey; Amylou Dueck; Kristi L Harold
Journal:  Can J Plast Surg       Date:  2011

Review 3.  Pubovaginal sling materials and their outcomes.

Authors:  Ömer Bayrak; David Osborn; William Stuart Reynolds; Roger Roman Dmochowski
Journal:  Turk J Urol       Date:  2014-12

4.  Solvent-dehydrated dermal allograft (AXIS™) augmented cystocele repair: longitudinal results.

Authors:  Saad Juma; Omer A Raheem
Journal:  Int Urogynecol J       Date:  2016-12-30       Impact factor: 2.894

5.  Sling and bulking agent placement procedures.

Authors:  Alfred E Bent
Journal:  Rev Urol       Date:  2004

6.  Medium-term follow-up on use of freeze-dried, irradiated donor fascia for sacrocolpopexy and sling procedures.

Authors:  Mary Pat FitzGerald; S Renee Edwards; Dee Fenner
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004 Jul-Aug

7.  Nonlinear and anisotropic tensile properties of graft materials used in soft tissue applications.

Authors:  Jonathon H Yoder; Dawn M Elliott
Journal:  Clin Biomech (Bristol, Avon)       Date:  2010-02-02       Impact factor: 2.063

8.  Biomaterials in urinary incontinence and treatment of their complications.

Authors:  Philippa Sangster; Roland Morley
Journal:  Indian J Urol       Date:  2010-04

9.  Ventral hernia repair using allogenic acellular dermal matrix in a swine model.

Authors:  R P Silverman; E N Li; L H Holton; K T Sawan; N H Goldberg
Journal:  Hernia       Date:  2004-12       Impact factor: 4.739

10.  Comparison of solvent-dehydrated allograft dermis and autograft rectus fascia for pubovaginal sling: questionnaire-based analysis.

Authors:  Rahmi Onur; Ajay Singla; Kathleen C Kobashi
Journal:  Int Urol Nephrol       Date:  2007-07-03       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.